Improvements in surgical technique: past and more recent

Nearly 3 years ago now, we first mentioned a surgical technique known as “Retzius-sparing” radical prostatectomy on this web site. … READ MORE …

Neoadjuvant CHT + surgery for men with high-risk, localized prostate cancer

Eastham et al. have recently reported — in the Journal of Clinical Oncology — results from a randomized Phase III trial of the surgical treatment of men with high-risk forms of localized prostate cancer. … READ MORE …

No survival benefit to debulking the prostate with radiation in first randomized clinical trial

The term “debulking” denotes the radical treatment (via prostatectomy or radiation therapy) of the cancerous prostate — lmost always in newly diagnosed patients — after distant metastases have been discovered. … READ MORE …

ORP vs. RALP re-visited

A newly published report in The Lancet Oncology has pretty much finally confirmed what many of us have been assuming for a long time now: … READ MORE …

Is Retzius-sparing radical prostatectomy the surgical wave of the future?

Back in the early 1980s, Dr. Patrick Walsh at the Johns Hopkins Medical Center in Baltimore changed the nature of surgical treatment for prostate cancer when he first started to conduct so-called nerve-sparing radical prostatectomies. … READ MORE …

Pre-surgical weight loss in the surgical treatment of prostate cancer

Overweight and obese prostate cancer patients are often advised to lose weight prior to surgery for the treatment of localized forms of prostate cancer. But is this really, always, a good idea? … READ MORE …

The end to WHAT controversy?

In an extraordinary editorial in the July issue of the Journal of Urology, Dr. Michael Koch of the University of Indiana School of Medicine makes the following statement: … READ MORE …

Early, adjuvant chemotherapy in high-risk patients after surgery

A paper presented yesterday at the now-completed annual meeting of the American Urological Association has given us new data on the role of adjuvant chemotherapy alone in the treatment of men with high-risk prostate cancer. … READ MORE …

Is salvage radical prostatectomy really being under-used?

A new paper in the journal Clinical Genitourinary Cancer states that, “Salvage radical prostatectomy (SRP) is a treatment modality for patients with radio-recurrent prostate cancer but is currently underutilized.” The “New” Prostate Cancer InfoLink is significantly less than convinced of that premise. … READ MORE …

Exactly who is doing your radical prostatectomy for you?

According to a newly published article in Urologic Oncology, at least 85 percent of all radical prostatectomies in America are now performed using robot-assisted laparoscopic prostatectomy (RALP). Actually, this is hardly a surprise. However, … READ MORE …

Neoadjuvant chemotherapy prior to surgery in higher-risk patients

A combined Russian and German research team has provided some interesting preliminary information on the use of neoadjuvant, low-dose docetaxel-based chemotherapy in treatment of intermediate- and high-risk patients prior to radical prostatectomy. … READ MORE …

Expectation management and sexual/erectile outcomes after radical prostatectomy

A newly published paper in BJU International has helped to make clear that many surgical patients have unrealistic expectations about their recovery of erectile and sexual function after radical prostatectomy. … READ MORE …

Long-term survival of high-risk patients < 60 years of age treated by radical prostatectomy

A multi-institutional, international study has provided us with data on the 10-, 15-, and 20-year survival of a cohort of 600 relatively young, high-risk prostate cancer patients, all of whom were treated with first-line radical prostatectomy. … READ MORE …

Understanding the range of risks associated with prostate cancer surgery today

It would certainly be difficult (and arguably impossible) for us to provide a newly diagnosed prostate cancer patient with a  comprehensive list of all the possible side effects and complications that might be associated with every type of first-line treatment for prostate cancer. However, … READ MORE …

Of ORPs and RALPs: data from the Victorian Prostate Cancer Registry

Data from just over 2,000 prostate cancer patients in the Victorian Prostate Cancer Registry (VPCR, from the State of Victoria, Australia) suggest some difference in outcomes between men receiving open and robot-assisted laparoscopic surgery for localized prostate cancer. … READ MORE …